Metadata
Author: patents-wipo
Data
English[en]
The present invention relates to a solid extended release pharmaceutical dosage form, comprising a mixture in the form of an extended release matrix formulation, the mixture comprising at least: (1) at least one poly(ε-caprolactone), and (2) at least one polyethylene oxide, and (3) at least one active agent.
French[fr]
Ladite matrice comprend au moins : (1) une poly(oxépan-2-one), (2) au moins un polyéthylène oxyde ainsi (3) qu'au moins un agent actif.